Mid Cap Pharma Stock Fixes Record Date For 425% Dividend, PL Says Buy, 5 Yrs Return 565%

Mid cap pharmaceuticals sector stock, J B Chemicals & Pharmaceuticals Ltd has fixed February 18, 2023 as the record date for 425% interim dividend. The stock offered a return of 255% in last 3-years.

Brokerage firm, Prabhudas Lilladher has assigned buy call to J B Chemicals & Pharmaceuticals with a target price of Rs 2350 apiece. If you buy J B Chemicals & Pharmaceuticals now, you will get potential return of 19%. Check details below:

1. J B Chemicals & Pharmaceuticals Sets Record Date For Interim Dividend

According to the BSE filing of the company, "This is to inform you that the Board of directors of the Company at its meeting held today has declared interim dividend of Rs. 8.50 per equity share of FV of Rs. 2 (425%) for financial year 2022-23."

The Company has fixed Saturday, February 18, 2023 as record date, to ascertain eligibility of the beneficial owners/shareholders of the Company to receive the interim dividend for FY 2022-2023.

2. J B Chemicals & Pharmaceuticals Stock Performance & Return

The last trading price of the stock is Rs 1983.75 apiece with an intraday fall of 2.56%. The stock's 52-week high is Rs 2149.90 apiece and 52-week low is Rs 1339.05 apiece, respectively.

The company has a market capitalisation of Rs 15,330.36 crore. The stock gave a return of 6% in last 6-months, 13% in last 1-year, 255% in last 3-years, and 565% in last 5-years.

3. J B Chemicals & Pharmaceuticals Valuation

According to Prabhudas Lilladher's brokerage report dated Nov 15, 2022, "We maintained our Buy rating on stock with revised TP of Rs2,350/share (Rs1950 earlier) as we roll forward, valuing at 25x (23x earlier) Sept 2024E EPS adjusted for ESOP and amortization charges."

4. J B Chemicals & Pharmaceuticals About

In the last one year, JB has become India's fastest growing pharmaceutical company, entering the list of India's top 25 pharmaceutical companies. JB is one of the few Indian pharma companies employing the OROS (Osmotic-controlled Oral delivery System) technology.

JB also has set an unmatched technological lead in lozenges as a drug delivery format and is today one of the world's top 5 manufacturers of medicated and herbal lozenges, according to its official website.

Disclaimer

The stock has been picked from the brokerage report of Prabhudas Lilladher. Greynium Information Technologies, the Author, and the respective Brokerage House are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.